EMA
approval
· 2026-02-12
EMA Authorised: Palforzia (defatted powder of Arachis hypogaea L., semen (peanuts)) — Stallergenes
Summary
The European Medicines Agency authorised Palforzia for peanut hypersensitivity in the EU. The product is a peanut allergen immunotherapy developed by Stallergen…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Status: Authorised. Therapeutic area: Peanut Hypersensitivity. MAH: Stallergenes. Decision date: 05/12/2025